Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H25NO3 |
Molecular Weight | 327.4174 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(C(=O)OCCN(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=RHUWRJWFHUKVED-UHFFFAOYSA-N
InChI=1S/C20H25NO3/c1-4-24-20(17-11-7-5-8-12-17,18-13-9-6-10-14-18)19(22)23-16-15-21(2)3/h5-14H,4,15-16H2,1-3H3
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095181 Sources: http://www.behavenet.com/dimenoxadol |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.drugfuture.com/chemdata/dimenoxadol.html
LD50 i.v. in rats: 66 mg/kg
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
||
|
DEA NO. |
9617
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C65400
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
DTXSID5057759
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
C005016
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
710
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
m1116
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL2104309
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
3149
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
SUB07160MIG
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
4D65PBX0VK
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
509-78-4
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
DIMENOXADOL
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
100000082636
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
DB01461
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY | |||
|
17036
Created by
admin on Fri Dec 15 16:34:24 GMT 2023 , Edited by admin on Fri Dec 15 16:34:24 GMT 2023
|
PRIMARY |
ACTIVE MOIETY